Nimbus Therapeutics - Funding, Financials, Valuation, Investors - Cointime

比特币 ¥771,233.37 +2.52%
以太坊 ¥18,595.37 +2.39%
币安币 ¥4,690.46 +1.31%
Optimism ¥4.35 +3.02%
Arbitrum ¥2.36 +0.74%
Solana ¥1,103.99 +1.77%
Polygon ¥1.56 +2.77%
Cosmos ¥30.29 +3.65%
Avalanche ¥139.50 +1.99%

比特币 ¥771,233.37 +2.52%
以太坊 ¥18,595.37 +2.39%
币安币 ¥4,690.46 +1.31%
Optimism ¥4.35 +3.02%
Arbitrum ¥2.36 +0.74%
Solana ¥1,103.99 +1.77%
Polygon ¥1.56 +2.77%
Cosmos ¥30.29 +3.65%
Avalanche ¥139.50 +1.99%

Nimbus Therapeutics

company

Investors

Number of Lead Investors

Number of Investors

7

17

Nimbus Therapeutics is funded by 17 investors. Access Biotechnology and Atlas Venture are the most recent investors.

Investor Name	Lead Investor	Funding Round
Access Biotechnology	-	Series Unknown
Atlas Venture	-	Series Unknown
Bain Capital Life Sciences	-	Series Unknown
Bill Gates	-	Series Unknown
Biotechnology Value Fund	-	Series Unknown
Lightstone Ventures	-	Series Unknown
Pfizer Venture Investments	-	Series Unknown
RA Capital Management	-	Series Unknown
SR One	-	Series Unknown
SV Health Investors	-	Series Unknown
Commodore Capital	-	Series Unknown
Logos Capital	-	Series Unknown
Surveyor Capital	-	Series Unknown
BVF Partners	-	Series Unknown
Lilly Ventures	-	Series C
Schrödinger	-	Series C
Richard Friesner	-	Seed